|
|
Effect of Recombinant Bovine Basic Fibroblast Grow Factor combined with Sodium Hyaluronate in the treatment of senile patients with dry eye after cataract surgery and its effect on tear film function and inflammatory factors |
YANG Hongyun |
Department of Ophthalmology, People′s Hospital of Xintai City, Shandong Province, Xintai 271200, China |
|
|
Abstract Objective To investigate the effect of Recombinant Bovine Basic Fibroblast Grow Factor (rb-bFGF) combined with Sodium Hyaluronate in the treatment of senile patients with dry eye after cataract surgery and its effect on tear film function and inflammatory factors. Methods A total of 76 elderly patients (76 eyes) with dry eye who were underwent cataract surgery in the People′s Hospital of Xintai City from November 2020 to October 2021 were selected as the research subjects, and they were divided into the treatment group (38 cases, 38 eyes) and the control group (38 cases, 38 eyes) by random touching-ball method. The control group was treated with Sodium Hyaluronate, the treatment group was treated with rb-bFGF combined with Sodium Hyaluronate. The clinical efficacy of the two groups were compared, and the tear film function and inflammatory factor levels were compared between the two groups before and after treatment. Results The total effective rate in treatment group was higher than that in control group, and the difference was statistically significant (P<0.05). After treatment, the tear film break-up time (BUT) levles of the two groups after treatment were longer than those before treatment, and the Schirmer Ⅰ test (SⅠt) lengths of the two groups were higher than those before treatment, corneal fluorescein staining (FL) scores of the two groups were lower than those before treatment, and BUT in treatment group after treatment was longer than that in control group, SⅠt in treatment group after treatment was higher than that in control group, FL score in treatment group after treatment was lower than that in control group, the differences were statistically significant (P<0.05). After treatment, the levels of interleukin-1β (IL-1β) and interleukin-8 (IL-8) in the two groups were lower than those before treatment, and compared, the levels of IL-1β and IL-8 in the treatment group after treatment were lower than those in the control group, and the differences were statistically significant (P<0.05). Conclusion The treatment of rb-bFGF combined with Sodium Hyaluronate in elderly patients with dry eye after cataract surgery can improve the clinical efficacy, improve tear film function and regulate the level of inflammatory factors.
|
|
|
|
|
[1] |
刘芳.普拉洛芬联合人工泪液对干眼症患者的临床效果及对炎性因子的影响[J].贵州医药,2020,44(2):247-248.
|
[2] |
薛磊,李新,彭芹,等.玻璃酸钠联合重组人表皮生长因子滴眼液对老年白内障术后干眼症泪膜的疗效[J].中国老年学杂志,2017,37(9):2268-2269.
|
[3] |
刘锦魁,唐健青.重组牛碱性成纤维细胞生长因子眼用凝胶在睑板腺异常相关干眼患者中的临床应用[J].海南医学,2017,28(4):658-659.
|
[4] |
中华医学会眼科学分会白内障及人工晶状体学组,姚克.中国白内障围手术期干眼防治专家共识(2021年)[J].中华眼科杂志,2021,57(1):17-22.
|
[5] |
中华医学会眼科学分会角膜病学组.干眼临床诊疗专家共识(2013年)[J].中华眼科杂志,2013,49(1):73-75.
|
[6] |
刘家琦,李凤鸣,吴静安,等.实用眼科学[M].3版.北京:人民卫生出版社,2017:30.
|
[7] |
陈娟,李爽乐.玻璃酸钠联合rhEGF滴眼液治疗白内障术后干眼症的疗效[J].中国老年学杂志,2021,41(14):3006-3009.
|
[8] |
胡杨,赵鸣,丁洁.rhEGF滴眼液治疗白内障术后干眼症的效果及对泪膜稳定性的影响[J].国际眼科杂志,2019, 19(8):1370-1372.
|
[9] |
田莉,吴永红.玻璃酸钠滴眼液联合重组牛碱性成纤维细胞生长因子滴眼液对干眼症患者症状改善情况的影响研究[J].中国全科医学,2017,20(A2):164-166.
|
[10] |
苏学刚.贝复舒滴眼液联合玻璃酸钠滴眼液治疗白内障术后角膜水肿的临床效果[J].药物评价研究,2018,41(2):275-278.
|
[11] |
杨彪,董凯.聚乙二醇滴眼液联合重组牛碱性成纤维细胞生长因子眼用凝胶对准分子术后干眼的作用[J].药品评价,2018,15(1):33-34,41.
|
[12] |
黄瑾.玻璃酸钠滴眼液联用贝复舒滴眼液治疗眼角结膜干燥症患者的临床疗效研究[J].重庆医学,2018,47(A1):132-134.
|
[13] |
陈鑫,沈烨宇.重组牛碱性成纤维细胞生长因子联合玻璃酸钠治疗超声乳化术后干眼[J].国际眼科杂志,2019, 19(2):280-284.
|
[14] |
曹小川.玻璃酸钠滴眼液联合贝复舒滴眼液治疗干眼症的效果及SAI评分分析[J].吉林医学,2020,41(2):361-362.
|
[15] |
钟珺.重组牛碱性成纤维细胞生长因子滴眼液在白内障术后干眼症患者中的应用效果[J].临床合理用药杂志,2020,13(18):93-94.
|
[16] |
凌宇,彭子春,唐琪,等.rb-bFGF滴眼液与羟糖苷滴眼液对年龄相关性白内障术后泪膜稳定性及干眼症状的影响[J].国际眼科杂志,2018,18(1):104-107.
|
[17] |
文中华,李元芳,张玉明,等.术前应用人工泪液联合rbFGF对白内障合并干眼患者术后眼表功能及泪液中炎症因子水平的影响[J].国际眼科杂志,2021,21(9):1529-1534.
|
[18] |
康斌,万金兰.聚乙二醇滴眼液联合重组牛碱性成纤维细胞生长因子眼用凝胶治疗睑板腺功能障碍型干眼症的临床效果[J].中国当代医药,2021,28(8):115-118.
|
|
|
|